Link copied to clipboard
Link copied to clipboard
Exclusive to subscribersYou can now gift articles
Roche agrees to buy Philadelphia biotech Spark Therapeutics for $4.3 billion, enriching CHOP, founders
The CHOP Foundation will collect at least $430 million for its Spark shares, plus other potential payments -- a huge return for the hospital’s $33 million investment since 2013.
